{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/VIR/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T04:44:00.518Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9712,"canonical_name":"Vir Biotechnology, Inc.","cik":"0001706431","uei":null,"lei":null,"duns":null,"ticker":"VIR"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":27,"clinical":3},"count":30,"timeline":[{"ts":"2026-10-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Vir Biotechnology, Inc. — 2026-10-08","url_slug":"/sec/cik-0001706431/8-k/0001628280-26-065408","accession_number":"0001628280-26-065408","importance":35},{"ts":"2026-10-06","kind":"sec.filing","form_type":"3","title":"3 — Vir Biotechnology, Inc. — 2026-10-06","url_slug":"/sec/cik-0001706431/3/0001628280-26-065222","accession_number":"0001628280-26-065222","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Vir Biotechnology, Inc. — 2026-10-01","url_slug":"/sec/cik-0001706431/8-k/0001628280-26-064117","accession_number":"0001628280-26-064117","importance":35},{"ts":"2026-09-17","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-09-17","url_slug":"/sec/cik-0001706431/144/0001959173-26-007020","accession_number":"0001959173-26-007020","importance":30},{"ts":"2026-09-09","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-09-09","url_slug":"/sec/cik-0001706431/144/0001959173-26-006814","accession_number":"0001959173-26-006814","importance":30},{"ts":"2026-08-25","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-08-25","url_slug":"/sec/cik-0001706431/144/0001959173-26-006425","accession_number":"0001959173-26-006425","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-08-24","url_slug":"/sec/cik-0001706431/144/0001959173-26-006413","accession_number":"0001959173-26-006413","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-08-21","url_slug":"/sec/cik-0001706431/144/0001959173-26-006329","accession_number":"0001959173-26-006329","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Vir Biotechnology, Inc. — 2026-08-07","url_slug":"/sec/cik-0001706431/schedule-13g/0000093751-26-000556","accession_number":"0000093751-26-000556","importance":55},{"ts":"2026-08-05","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Vir Biotechnology, Inc. — 2026-08-05","url_slug":"/sec/cik-0001706431/10-q/0001628280-26-053549","accession_number":"0001628280-26-053549","importance":45},{"ts":"2026-08-05","kind":"sec.filing","form_type":"8-K","title":"8-K — Vir Biotechnology, Inc. — 2026-08-05","url_slug":"/sec/cik-0001706431/8-k/0001628280-26-053351","accession_number":"0001628280-26-053351","importance":35},{"ts":"2026-07-31","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vir Biotechnology, Inc. — 2026-07-31","url_slug":"/sec/cik-0001706431/schedule-13g-a/0002100121-26-000992","accession_number":"0002100121-26-000992","importance":30},{"ts":"2026-07-24","kind":"sec.filing","form_type":"8-K","title":"8-K — Vir Biotechnology, Inc. — 2026-07-24","url_slug":"/sec/cik-0001706431/8-k/0001628280-26-049499","accession_number":"0001628280-26-049499","importance":35},{"ts":"2026-06-29","kind":"sec.form144","reporter":"Ramasastry Saira","title":"Former Director","shares":16000,"usd_value":165139,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001959173-26-004947","importance":40.03302779},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Ramasastry Saira — 2026-06-29","url_slug":"/sec/cik-0001547959/144/0001959173-26-004947","accession_number":"0001959173-26-004947","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"8-K","title":"8-K — Vir Biotechnology, Inc. — 2026-06-10","url_slug":"/sec/cik-0001706431/8-k/0001628280-26-042237","accession_number":"0001628280-26-042237","importance":35},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"Coughlin Timothy","title":null,"shares":8000,"price_per_share":0,"usd_value":0,"security_title":"Common  Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.a","reporter":"Coughlin Timothy","title":null,"shares":8000,"price_per_share":0,"usd_value":0,"security_title":"Common  Stock","importance":15},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Vir Biotechnology, Inc. — 2026-06-02","url_slug":"/sec/cik-0001706431/4/0001628280-26-039938","accession_number":"0001628280-26-039938","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"4","title":"4 — Vir Biotechnology, Inc. — 2026-06-02","url_slug":"/sec/cik-0001706431/4/0001628280-26-039943","accession_number":"0001628280-26-039943","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"Napolitano Janet","title":"Director","shares":3200,"usd_value":30240,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001959173-26-004187","importance":40.006048},{"ts":"2026-06-01","kind":"sec.form144","reporter":"Sabatini Brent","title":"Officer","shares":379,"usd_value":3582,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001959173-26-004199","importance":40.00071631},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Napolitano Janet","title":null,"shares":3200,"price_per_share":9.45,"usd_value":30240,"security_title":"Common Stock","importance":35.03024},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Sabatini Brent","title":"SVP,  Chief Accounting Officer","shares":379,"price_per_share":9.45,"usd_value":3582,"security_title":"Common  Stock","importance":35.00358155},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-06-01","url_slug":"/sec/cik-0001706431/144/0001959173-26-004187","accession_number":"0001959173-26-004187","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Vir Biotechnology, Inc. — 2026-06-01","url_slug":"/sec/cik-0001706431/144/0001959173-26-004199","accession_number":"0001959173-26-004199","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Vir Biotechnology, Inc. — 2026-05-15","url_slug":"/sec/cik-0001706431/schedule-13g-a/0001493152-26-024001","accession_number":"0001493152-26-024001","importance":30},{"ts":"2026-05-06","kind":"clinical.trial","reporter":"Vir Biotechnology, Inc.","title":"A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide","security_title":"PHASE3","status":"RECRUITING","accession_number":"NCT07128550","excerpt":"[\"Viral Hepatitis\"]","importance":60},{"ts":"2026-04-23","kind":"clinical.trial","reporter":"Vir Biotechnology, Inc.","title":"Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection","security_title":"PHASE2","status":"COMPLETED","accession_number":"NCT04856085","excerpt":"[\"Hepatitis B, Chronic\"]","importance":45},{"ts":"2026-04-20","kind":"clinical.trial","reporter":"Vir Biotechnology, Inc.","title":"Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer","security_title":"PHASE1","status":"RECRUITING","accession_number":"NCT05997615","excerpt":"[\"Hormone-refractory Prostate Cancer\"]","importance":30}]}